Characteristic | Patients (n = 40) |
---|---|
Age, years, median (range) | 56 (27–76) |
ECOG PS score, n (%) | Â |
 0 | 3 (7.5%) |
 1 | 37 (92.5%) |
Number of metastatic sites, median (range) | 2 (0–5) |
Metastatic sites, n (%) | Â |
 Lymph nodes | 25 (62.5%) |
 Lung | 9 (22.5%) |
 Liver | 9 (22.5%) |
 Others* | 26 (65.0%) |
Previous lines of chemotherapy in the advanced setting, median (range) | 2 (1–5) |
Previous therapy in the advanced setting, n (%) | Â |
 Taxane | 24 (60.0%) |
 Anthracycline | 32 (80.0%) |
 Platinum | 20 (50.0%) |
 Others# | 34 (85.0%) |